|
Activities of ten agents against 109 isolates of carbapenem-resistant P. aeruginosa isolates obtained from patients with BSI over a six-year period. |
||||
| Agent |
MIC50 μg/mL |
MIC90 μg/mL |
Range μg/mL |
% Susceptibility |
|
|
||||
| Aztreonam |
64 |
128 |
1 – >128 |
7.4 |
| Cefepime |
32 |
128 |
<0.25 – >128 |
7.3 |
| Ceftazidime |
128 |
>128 |
<0.25 – >128 |
8.3 |
| Ciprofloxacin |
32 |
64 |
<0.25 – 64 |
6.4 |
| Colistin |
1 |
1 |
<0.25 – 2 |
100 |
| Gentamicin |
>128 |
>128 |
0.5 – >128 |
20.2 |
| Imipenem |
64 |
256 |
16 – 1,024 |
0 |
| Meropenem |
32 |
256 |
2 – 1,024 |
1.8 |
| Piperacillin/Tazobactam |
>128 |
>128 |
1 – >128 |
13.8 |
| Polymyxin B |
0.5 |
1 |
<0.25 – 8 |
99.1 |
van der Heijden et al. Annals of Clinical Microbiology and Antimicrobials 2007 6:8 doi:10.1186/1476-0711-6-8 |
||||